In a new study, researchers demonstrated that vasculature-like signals (N) in chest computed tomography (CT) scans could serve as robust imaging biomarkers (IBs) of early-stage COVID-19 screening.
Exploring the use of chest CT-based imaging biomarkers for early-stage COVID-19 screening
In a new study, researchers demonstrated that vasculature-like signals (N) in chest computed tomography (CT) scans could serve as robust imaging biomarkers (IBs) of early-stage COVID-19 screening.